Stay informed with the Divis Labs Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Stay up-to-date with the Divis Labs Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

Pharma stock Laurus Labs advanced 2.42 per cent to Rs 1,039.70.  Divis Laboratories Ltd gained 1.87 per cent to Rs 6500.10. Gland Pharma added 0.34 per cent to Rs 1,671.55.

The 64-page bill proposes a new certification exam for ‘accredited investors’ and would allow 403(b) plans to invest in the same products as 401(k) plans.

Bajaj Broking Research highlights Eternal and Divi's Laboratories as top stock picks for December 12, 2025. Nifty is exp ...

The stock of Divi’s Laboratories (₹6,473.50) has been moving in a long range between ₹5,250 and ₹7,000 in the last one year. Immediate support levels are at ₹6,359 and ₹6,200. Nearest resistances are ...

Divi’s Laboratories has reported a positive regulatory development, confirming that the US Food and Drug Administration (USFDA) has successfully completed a comprehensive cGMP inspection at the ...

Investing.com - Jefferies has raised its price target on Divi’s Laboratories Ltd (NS:DIVI) to INR7,850 from INR7,150 while maintaining a Buy rating following the company’s September quarter results.

Hyderabad: Divi's Laboratories registered a 35% jump in consolidated net profit for the second quarter ended September 30, 2025, at 689 crore compared to 510 crore in the corresponding quarter of the ...

New Delhi, Nov 7 (PTI) Pharmaceuticals firm Divi's Laboratories Ltd on Friday reported a 35 per cent rise in consolidated net profit at Rs 689 crore in the second quarter ended September 30, 2025 on ...

Friday, Nov 7 | Hyderabad: Divi’s Laboratories Limited has announced the appointment of Mr. Nimmagadda Venkata Anirudh as President (Nutraceuticals) and Senior Management Personnel, effective November ...

Divi’s Laboratories Ltd. delivered a strong performance in the September quarter, comfortably exceeding market expectations with growth across all major financial indicators. The Hyderabad-based drug ...